Vraylar 1.5 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FR8ZM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,331
Award facts
- Contract value 100% obligated
- $55,330.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $55,330.86 by the Defense Logistics Agency (DLA) on January 21, 2026, for the supply of Vraylar 1.5 mg capsules (30-count units). This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of January 22, 2026, and represents no set-aside contract. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at up to $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
As a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), AmerisourceBergen Drug Corp maintains a critical role in the federal pharmaceutical supply chain, particularly serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Vraylar, a neurological treatment medication, exemplifies the specialized pharmaceutical commodities the contractor regularly delivers through its DLA contract vehicle. The delivery order structure and firm fixed-price mechanism demonstrate the company's established capability to efficiently fulfill government requirements for essential prescription medications required by military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FR8ZM?
SPE2DR26FR8ZM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FR8ZM worth?
The government has obligated $55,331 on SPE2DR26FR8ZM.
Is contract SPE2DR26FR8ZM an order under another contract?
Yes. SPE2DR26FR8ZM is a delivery order under SPE2DR25D3018, an indefinite delivery contract.
Was contract SPE2DR26FR8ZM competed?
The extent of competition for SPE2DR26FR8ZM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award